Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon alfa-2b vs Mitomycin C in CIN
NCT02199327Phase 4Completed
- Sponsor
- Coordinación de Investigación en Salud
- Start
- May 2014
- Primary completion
- Dec 2016
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in conjunctival intraepithelial neoplasia (OSSN) and Corneal intraepithelial neoplasia (CIN) comparing Mitomycin C with Interferon alfa 2b (2 arms). Primary endpoint: Therapeutic effect - 100% resolution. Started May 2014; status: completed.
02
Drugs
interferon alfa-2bmitomycin c
03
Conditions
conjunctival intraepithelial neoplasia (OSSN)Corneal intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT02199327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02199327.